CAVE CREEK, AZ — (Marketwired) — 12/14/15 — Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today the imminent completion of a company audit with the auditing firm, Anton & Chia.
Upon filing of 2015 financials, Endexx will have three years of fully audited financials. As an SEC filer, the Company will be up-listed to OTCQB status and maintain a fully audited status on an annual basis.
Upon completion of the audit and up-listing, the Company will announce the structure and composition of its investment banking syndicate and proceed to file a registration statement with the Securities and Exchange Commission to raise growth capital dedicated to the expansion of product lines, sales and marketing, R&D and strategic acquisitions.
Todd Davis, Endexx CEO, stated: “Maintaining an audited status opens the door to institutional investors and financing structures that better serve our capital growth needs. Since January 2013, Endexx–s shareholder base has organically grown from 400 to over 5700. Our commitment to our shareholders is paramount as we navigate a business environment that produces many challenges. Endexx is now able to execute at a national level with both our Cannsumable division and the M3 Technology platform.”
Endexx provides innovative medical marijuana management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. The company has two technology products and services that launched in 2014 — the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to an eventual federal mandates. The Autospense is a high-tech marijuana inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense increases productivity and reduces costs for marijuana retailer, while enhancing their service quality by reducing transaction time for customers. Websites include: , , , .
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company–s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company–s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company–s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Todd Davis
Chairman & CEO
480-595-6900
Robert Haag
Managing Director
866-976-4784
You must be logged in to post a comment Login